Abstract LncRNA N6-methylandenosine (m6A) modification has been shown to be
associated with the constitution of the tumor microenvironment (TME) and tumorigenesis. It's …

HCC is one of the most common types of malignancies worldwide and the fourth-leading
cause of cancer deaths. Thus, there is an urgent need to search for novel targeted therapies …

The relationship between m6A-related lncRNAs and prognosis in hepatocellular carcinoma
(HCC) is not yet clear. We used Lasso regression to establish a prognostic signature based …

Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …

Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …

We aimed to illustrate the influence of N6-methyladenosine (m6A) long non-coding RNAs
(lncRNAs) and immune cell infiltration in hepatocellular carcinoma (HCC). The relationship …

Objective To study the role of m6A and lncRNAs in the prognosis and immunotherapy of
hepatocellular carcinoma, construct the risk score of overall survival of hepatocellular …

Objective: The purpose of this study was to establish an N6-methylandenosine (m6A)-
related long non-coding RNA (lncRNA) signature to predict the prognosis of hepatocellular …

Abstract N6-methyladenosine (m6A) methyltransferase has been shown to be an oncogene
in a variety of cancers. Nevertheless, the relationship between the long non-coding RNAs …

Background: RNA methylation modifications are important post-translational modifications
that are regulated in an epigenetic manner. Recently, N 6-methyladenosine (m 6 A) RNA …